Yahoo India Web Search

Search results

1. www.researchgate.net › profile › Thomas-BretschneiderThomas BRETSCHNEIDER | TU Wien, Vienna | TU Wien | Institute ...

   www.researchgate.net › profile › Thomas-Bretschneider

   Thomas BRETSCHNEIDER | Cited by 13 | of TU Wien, Vienna (TU Wien) | Read 2 publications | Contact Thomas BRETSCHNEIDER

   • Thomas Bretschneider's research works

     Thomas Bretschneider's 27 research works with 483 citations...

2. Images

   • 
   • 
   • 
   • 
   • 
   • 

   View all

3. www.facebook.com › public › Thomas-BretschneiderThomas Bretschneider Profiles | Facebook

   www.facebook.com › public › Thomas-Bretschneider

   View the profiles of people named Thomas Bretschneider. Join Facebook to connect with Thomas Bretschneider and others you may know. Facebook gives people...

4. www.researchgate.net › scientific-contributionsThomas Bretschneider's research works | Bayer, Leverkusen and ...

   www.researchgate.net › scientific-contributions

   Thomas Bretschneider's 27 research works with 483 citations and 5,835 reads, including: Biphenyl-substituted spirocyclic ketoenols

5. www.linkedin.com › pub › dir20+ "Thomas Bretschneider" profiles | LinkedIn

   www.linkedin.com › pub › dir

   There are 20+ professionals named "Thomas Bretschneider", who use LinkedIn to exchange information, ideas, and opportunities.

6. www.ncbi.nlm.nih.gov › pmc › articlesTheoretical and Practical Aspects in the Use of Bretschneider ...

   www.ncbi.nlm.nih.gov › pmc › articles

   Jun 2, 2022 · The Bretschneider solution, belonging to the “intracellular cardioplegic” group, is safe and practical in myocardial protection during ischemic time. Over time, some particular concerns have arisen regarding the effects on cardiac metabolism and postoperative myocardial functioning.

   • DOI: 10.3390/jcdd9060178
   • Published: 2022/06

   • Publication: J Cardiovasc Dev Dis. 2022 Jun; 9(6): 178.

7. patents.justia.com › inventor › thomas-bretschneiderThomas Bretschneider Inventions, Patents and Patent ...

   patents.justia.com › inventor › thomas-bretschneider

   • Cached

   Thomas Bretschneider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

8. People also ask

   Is Bretschneider safe during ischemic time?

   • The Bretschneider solution, belonging to the “intracellular cardioplegic” group, is safe and practical in myocardial protection during ischemic time. Over time, some particular concerns have arisen regarding the effects on cardiac metabolism and postoperative myocardial functioning.

   Theoretical and Practical Aspects in the Use of Bretschneider

   www.ncbi.nlm.nih.gov/pmc/articles/PMC9225441/

   See all results for this question

   Is Bretschneider a good cardioplegic solution?

   • Enrico Ferrari, Academic Editor and Monique R.M. Jongbloed, Academic Editor The race for an ideal cardioplegic solution has remained enthusiastic since the beginning of the modern cardiac surgery era. The Bretschneider solution, belonging to the “intracellular cardioplegic” group, is safe and practical in myocardial protection during ischemic time.

   Theoretical and Practical Aspects in the Use of Bretschneider

   www.ncbi.nlm.nih.gov/pmc/articles/PMC9225441/

   See all results for this question

   Does Bretschneider cause myocardial edema?

   • In some early studies, the Bretschneider solution was considered the culprit for causing myocardial edema, especially in complex cardiac interventions with prolonged cardiac arrest and repeat administration [ 78, 79 ].

   Theoretical and Practical Aspects in the Use of Bretschneider

   www.ncbi.nlm.nih.gov/pmc/articles/PMC9225441/

   See all results for this question

   What is Bretschneider cardioplegia?

   • The Bretschneider cardioplegia—preventing the exhaustion of energy constituents and preserving ultrastructural integrity—is suitable for cold static preservation of the heart at a temperature of 2–4 °C when transporting it to the recipient’s site, approved by the U.S. Food and Drug Administration [ 71, 72, 73, 74 ].

   Theoretical and Practical Aspects in the Use of Bretschneider

   www.ncbi.nlm.nih.gov/pmc/articles/PMC9225441/

   See all results for this question

9. www.instagram.com › tbretschneiderThomas Bretschneider (@tbretschneider) - Instagram

   www.instagram.com › tbretschneider

   425 Followers, 877 Following, 115 Posts - See Instagram photos and videos from Thomas Bretschneider (@tbretschneider)